Sinovac Biotech Performance

The entity has beta of 0.0 which indicates the returns on MARKET and Sinovac Biotech are completely uncorrelated. Although it is extremely important to respect Sinovac Biotech current price movements, it is better to be realistic regarding the information on equity historical returns. The philosophy towards measuring future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting Sinovac Biotech technical indicators you can presently evaluate if the expected return of 0.0% will be sustainable into the future. Sinovac Biotech right now has a risk of 0.0%. Please validate Sinovac Biotech Variance, Maximum Drawdown as well as the relationship between Maximum Drawdown and Semi Variance to decide if Sinovac Biotech will be following its existing price patterns.
00

Risk-Adjusted Performance

Over the last 30 days Sinovac Biotech Ltd has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Sinovac Biotech is not utilizing all of its potentials. The current stock price disturbance, may contribute to short term losses for the investors.
Quick Ratio4.43
Fifty Two Week Low6.25
Target High Price6.00
Fifty Two Week High6.58
Target Low Price6.00
Horizon     30 Days    Login   to change

Sinovac Biotech Relative Risk vs. Return Landscape

If you would invest (100.00)  in Sinovac Biotech Ltd on August 18, 2019 and sell it today you would earn a total of  100.00  from holding Sinovac Biotech Ltd or generate -100.0% return on investment over 30 days. Sinovac Biotech Ltd is generating negative expected returns assuming volatility of 0.0% on return distribution over 30 days investment horizon. In other words, 0% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 

Sinovac Biotech Market Risk Analysis

Sharpe Ratio = 0.0
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
SVA
Based on monthly moving average Sinovac Biotech is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sinovac Biotech by adding it to a well-diversified portfolio.

Sinovac Biotech Alerts

Equity Alerts and Improvement Suggestions

Sinovac Biotech is not yet fully synchronised with the market data
Sinovac Biotech has some characteristics of a very speculative penny stock
See also World Market Map. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.
Search macroaxis.com